rifampin

Generic: rifampin

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rifampin
Generic Name rifampin
Labeler asclemed usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rifampin 300 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-060
Product ID 76420-060_b1aea89e-52fb-b32e-e053-2995a90a032b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA064150
Listing Expiration 2026-12-31
Marketing Start 1997-05-28

Pharmacologic Class

Established (EPC)
rifamycin antibacterial [epc]
Chemical Structure
rifamycins [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420060
Hyphenated Format 76420-060

Supplemental Identifiers

RxCUI
198202
UNII
VJT6J7R4TR
NUI
N0000175500 M0019113

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rifampin (source: ndc)
Generic Name rifampin (source: ndc)
Application Number ANDA064150 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 14 CAPSULE in 1 BOTTLE (76420-060-14)
  • 30 CAPSULE in 1 BOTTLE (76420-060-30)
  • 60 CAPSULE in 1 BOTTLE (76420-060-60)
source: ndc

Packages (3)

76420-060-14 14 CAPSULE in 1 BOTTLE (76420-060-14) 76420-060-30 30 CAPSULE in 1 BOTTLE (76420-060-30) 76420-060-60 60 CAPSULE in 1 BOTTLE (76420-060-60)

Ingredients (1)

rifampin (300 mg/1)

Linked Drug Pages (1)

Rifampin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b1aea89e-52fb-b32e-e053-2995a90a032b", "openfda": {"nui": ["N0000175500", "M0019113"], "unii": ["VJT6J7R4TR"], "rxcui": ["198202"], "spl_set_id": ["e7b0571a-1bb8-45be-94cd-3539d314af69"], "pharm_class_cs": ["Rifamycins [CS]"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "14 CAPSULE in 1 BOTTLE (76420-060-14)", "package_ndc": "76420-060-14", "marketing_start_date": "20201015"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (76420-060-30)", "package_ndc": "76420-060-30", "marketing_start_date": "20201015"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (76420-060-60)", "package_ndc": "76420-060-60", "marketing_start_date": "20201015"}], "brand_name": "Rifampin", "product_id": "76420-060_b1aea89e-52fb-b32e-e053-2995a90a032b", "dosage_form": "CAPSULE", "pharm_class": ["Rifamycin Antibacterial [EPC]", "Rifamycins [CS]"], "product_ndc": "76420-060", "generic_name": "Rifampin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rifampin", "active_ingredients": [{"name": "RIFAMPIN", "strength": "300 mg/1"}], "application_number": "ANDA064150", "marketing_category": "ANDA", "marketing_start_date": "19970528", "listing_expiration_date": "20261231"}